Insiders Genmab A/S

Equities

GMAB

DK0010272202

Market Closed - Nasdaq Copenhagen Other stock markets 08:50:00 13/09/2024 pm IST			5-day change	1st Jan Change
1,800.00 ^DKK	+1.18%		-3.49%	-16.47%

09/09	Truist Lowers Price Target on Genmab to $50 From $53, Maintains Buy Rating	MT
04/09	Transcript : Genmab A/S Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-04-2024 01:05 PM

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HOOKIPA Pharma Names Julie O'Neill Nonexecutive Chair	30/08	MT
Genmab Names First Chief Technology, Chief Commercial Officers; COO to Exit	16/08	MT
Genmab COO Anthony Mancini Departs; Firm Names New CTO, CCO	16/08	MT
Genmab Operations Chief Anthony Mancini Departing	16/08	MT
Genmab A/S Announces Executive Changes	16/08	CI
Genmab A/S Announces Executive Changes	14/03	CI
Danish Biotechnology Group Genmab Names New Chief Strategy Officer	28/23/28	MT
Genmab A/S Announces Appointment of Martine van Vugt to Chief Strategy Officer and Promotes to Executive Vice President Effective March 29, 2023	28/23/28	CI
Avantor Names Jonathan Peacock Chairman	13/22/13	MT
Genmab A/S Elects Elizabeth O’Farrell to the Board of Directors	29/22/29	CI
Genmab Appoints New Chief Legal Officer, Chief People Officer	01/22/01	MT
Genmab A/S Announces Appointments of Birgitte Stephensen to Chief Legal Officer and Chris Cozic to Chief People Officer	01/22/01	CI
Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, Head of Experimental Medicines	22/21/22	CI
Genmab A/S Appoints Pernille Erenbjerg as Deputy Chairman	27/20/27	CI
Genmab A/S Announces the Election of Mr. Jonathan Peacock to its Board of Directors for a One-Year Period	26/20/26	CI
Genmab A/S Announces Anthony Mancini Will Join the Company as Executive Vice President and Chief Operating Officer, Effective March 23, 2020	10/20/10	CI
Genmab' Chairman of the Board of Directors, Mats Pettersson to Step Down from the Board At Annual General Meeting on March 26, 2020	22/20/22	CI
Genmab A/S Announces Executive Changes	31/19/31	CI
Genmab A/S Announces Management Changes	11/19/11	CI
Genmab A/S Appoints Judith Klimovsky as Executive Vice President and Chief Development Officer, Effective February 13, 2017	08/17/08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GENMAB : Better-than-expected Q2 + guidance upgrade

August 09, 2024 at 09:14 pm IST